APA (7th ed.) Citation

YG, G., M, W., RF, C., X, X., Q, L., NL, L., . . . HS, C. (2007). N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modifications. Journal of medicinal chemistry, 50(5), 1078. https://doi.org/10.1021/jm070035a

Chicago Style (17th ed.) Citation

YG, Gu, et al. "N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy Derivatives as Acetyl-coA Carboxylase Inhibitors--improvement of Cardiovascular and Neurological Liabilities via Structural Modifications." Journal of Medicinal Chemistry 50, no. 5 (2007): 1078. https://doi.org/10.1021/jm070035a.

MLA (9th ed.) Citation

YG, Gu, et al. "N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy Derivatives as Acetyl-coA Carboxylase Inhibitors--improvement of Cardiovascular and Neurological Liabilities via Structural Modifications." Journal of Medicinal Chemistry, vol. 50, no. 5, 2007, p. 1078, https://doi.org/10.1021/jm070035a.